Iris Personalized Medicine, a division of Iris International, is dedicated to enabling the advancement of predictive and personalized cancer treatment options. To find out more about Iris Personalized Medicine, click here.
Iris Personalized Medicine introduces NADiA ProsVue, a novel, personalized approach that peers through the cloud of imprecise information to provide a clearer view of the risk of clinical recurrence of prostate cancer for each patient. To find out more about the NADiA technology click here.
ASCO GU Symposium
Date: February 14-16 Location: Orlando, FL
UCSD Urology Post Graduate Course
Date: March 22-23 Location: San Diego, CA
American Urological Association (AUA)
Date: May 4-8
Location: San Diego, CA
Experience NADiA ProsVue first hand at upcoming events.
Details will be posted as we add new dates to our calendar, so check back often!